Miguel Villarreal Parra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel Villarreal Parra has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro I. Recio-Balsells
Instituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina
1 shared publication - Chantal Reigada
Instituto de Investigaciones Médicas A. Lanari, Facultad de Medicina, Universidad de Buenos Aires, Avenida Combatientes de Malvinas 3150, Buenos Aires 1427, Argentina
1 shared publication - Claudio A. Pereira
Facultad de Medicina, Instituto de Investigaciones Médicas A. Lanari, Universidad de Buenos Aires, Buenos Aires 1113, Argentina
1 shared publication - Esteban Panozzo-Zénere
Instituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, Rosario 2000, Argentina
1 shared publication - Guillermo R. Labadie
Instituto de Química Rosario (IQUIR-CONICET-UNR), Universidad Nacional de Rosario
1 shared publication - Juan C. Engel
Department of Pathology, Sandler Center for Drug Discovery, University of California San Francisco, San Francisco, CA 94158-2330, USA
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 119
Mechanistic Exploration of N,N′-Disubstituted Diamines as Promising Chagas Disease Treatments
Introduction: Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a major public health concern due to the limited effectiveness of current treatments, especially in the chronic stage. Objective: Here, we wanted to advance a library of 30 N,N′-disubstituted diamines as promising antichagasic agents and gain insight into the mechanism of action. Methods: The library was evaluated for activity against the T. cruzi amastigote stage and trypanocidal efficacy. In addition, selected compounds were tested as potential polyamine transport inhibitors, and a fluorescent analog was employed to investigate compound internalization. Results: Five compounds exhibited potent activity (pIC50 > 6.0), particularly those with short aliphatic linkers (3–6 carbon atoms), suggesting a structure–activity relationship favouring shorter chains. Mechanistic studies showed that compound 3c strongly inhibited polyamine transport, a vital pathway in T. cruzi, though this was not a universal mechanism among active hits, indicating the potential for multiple targets. A fluorescent analog confirmed intracellular uptake in amastigotes but lacked antiparasitic activity, likely due to disrupted pharmacophoric features. Importantly, none of the compounds demonstrated trypanocidal activity in long-term assays, and some showed cytotoxicity, particularly in the benzyloxy-substituted series. Conclusions: These findings position N,N′-disubstituted diamines as a viable scaffold for Chagas disease drug discovery. However, further optimization is required to enhance selectivity, achieve trypanocidal effects, and better understand the underlying mechanisms of action.
- 9 January 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 119
Open AccessMechanistic Exploration of N,N′-Disubstituted Diamines as Promising Chagas Disease Treatments
Introduction: Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a major public health concern due to the limited effectiveness of current treatments, especially in the chronic stage. Objective: Here, we wanted to advance a library of 30 N,N′-disubstituted diamines as promising antichagasic agents and gain insight into the mechanism of action. Methods: The library was evaluated for activity against the T. cruzi amastigote stage and trypanocidal efficacy. In addition, selected compounds were tested as potential polyamine transport inhibitors, and a fluorescent analog was employed to investigate compound internalization. Results: Five compounds exhibited potent activity (pIC50 > 6.0), particularly those with short aliphatic linkers (3–6 carbon atoms), suggesting a structure–activity relationship favouring shorter chains. Mechanistic studies showed that compound 3c strongly inhibited polyamine transport, a vital pathway in T. cruzi, though this was not a universal mechanism among active hits, indicating the potential for multiple targets. A fluorescent analog confirmed intracellular uptake in amastigotes but lacked antiparasitic activity, likely due to disrupted pharmacophoric features. Importantly, none of the compounds demonstrated trypanocidal activity in long-term assays, and some showed cytotoxicity, particularly in the benzyloxy-substituted series. Conclusions: These findings position N,N′-disubstituted diamines as a viable scaffold for Chagas disease drug discovery. However, further optimization is required to enhance selectivity, achieve trypanocidal effects, and better understand the underlying mechanisms of action.